Topic: John Fleetwood

Investigative journalist John Fleetwood explains the corporate connections between Merck, the manufacturer of the Ebola vaccine, and major asset managers like BlackRock and Vanguard. He notes that BlackRock CEO Larry Fink and Bill Gates are official partners of the World Economic Forum, which promotes a depopulation agenda. Fleetwood emphasizes that the FDA's own inserts confirm the vaccine's live status and shedding capabilities.

John Fleetwood and Dr. Bartlett discuss the dangers of Remdesivir, noting it had a 53% death rate in African Ebola trials according to the New England Journal of Medicine. They also reference the federal court case where the FDA attempted to hide Pfizer vaccine data for 75 years. The discussion reveals that the US military is currently funding Red Hill Biopharma to develop new Ebola drugs intended for use alongside Remdesivir.

John Fleetwood provides a detailed breakdown of the FDA insert for the Ervebo Ebola vaccine. He cites page 11, section 12.3, which explicitly lists "shedding" as a factor, occurring in 31.7% of subjects. The insert also confirms that the vaccine has not been tested for carcinogenicity, genotoxicity, or its effects on male and female fertility.